Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: Corneal Refractive Therapy Design Comparison for -4 to -6 Diopter Treatment for Overnight Wear for Myopia [NA]

View source ↗

Summary

A completed trial evaluated different corneal refractive therapy designs for overnight wear to treat myopia in the -4 to -6 diopter range.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corneal refractive therapy device (corneal refractive therapy device)

Snippet

Sponsor: CooperVision International Limited (CVIL) | Conditions: Myopia | NA | Status: COMPLETED